Acuamark Diagnostics

Private

New York City, New YorkHealthcare & Life Scienceshttps://acuamarkdx.com/

Last Round

Series A

Extension

Jun 4, 2024

Total Funding Raised

$17.72M

Company Overview

Acuamark Diagnostics is a molecular diagnostics company developing blood-based screening technology for the early detection of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

cancer diagnosticsliquid biopsyearly cancer detectionbiomarker detectionprecision medicinemolecular diagnosticsblood-based screeningquantitative polymerase chain reactionqPCRdigital polymerase chain reactiondPCRdiagnostic assayclinical laboratory servicesmethylation analysispredictive machine learningmulti-cancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acuamark Diagnostics Comparables

Compare Acuamark Diagnostics with similar companies based on industry and business-model similarity.

Acuamark Diagnostics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Harbinger Health	87%
Adela	84%
EarlyDiagnostics	83%

View all Comparables

Acuamark Diagnostics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jun 4, 2024
Series A	Jul 19, 2022
Private Placement	Dec 27, 2019
VC Round	Sep 25, 2019
Seed	Nov 17, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Bernard Peperstraete

Cofounder & CEO

Founding Team

Acuamark Diagnostics Investors

Notable investors and investment history

Acuamark Diagnostics investors
Investor	Rounds
XLerateHealth	Accelerator
Harvard Business School Alumni Angels of Greater New York	Seed

View all Investors

Acuamark Diagnostics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Acuamark Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acuamark Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range8

Year Founded2013

Last FundingJun 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.